Proteome Sciences (LON:PRM) Stock Price Down 14.1% – What’s Next?

Proteome Sciences plc (LON:PRM)’s stock price traded down 14.1% during mid-day trading on Monday . The stock traded as low as GBX 2.33 ($0.03) and last traded at GBX 2.36 ($0.03). 478 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 157,244 shares. The stock had previously closed at GBX 2.75 ($0.03).

Proteome Sciences Price Performance

The company has a 50-day moving average price of GBX 2.80 and a 200-day moving average price of GBX 3.29. The firm has a market capitalization of £8.45 million, a PE ratio of -286.40 and a beta of 0.07.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.